Company profile: Noroit
1.1 - Company Overview
Company description
- Provider of protective equipment against biological risks, including airflow cabinets and modules, isolators, and cabinets for animal production science, serving medical research, pharmaceutical industry and industry; products based on laminar airflow and physical containment technologies.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Noroit
Torax Biosciences
HQ: United Kingdom
Website
- Description: Provider of innovative quality controls and IVD reagents for clinical laboratories, creating, developing, and producing these products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Torax Biosciences company profile →
JEOL
HQ: United States
Website
- Description: Provider of SEM and TEM (including cryo-EM) for high-resolution imaging and analysis, mass spectrometers for protein characterization, pharmaceuticals and high-throughput screening, NMR spectrometers for molecular structure analysis, EPMA for elemental analysis and high spatial resolution imaging, and FIB systems for sample preparation, imaging and analysis; based in Peabody.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full JEOL company profile →
Accellix
HQ: Israel
Website
- Description: Provider of a bench-top automated cell phenotyping platform for cell therapy quality control, integrating sample preparation, flow cytometry, and data analysis; pre-configured and custom assay kits for GMP workflows; algorithm-based autoanalysis for real-time cell subset classification; and QC assays to verify instrument performance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Accellix company profile →
Univercells
HQ: Belgium
Website
- Description: Provider of end-to-end, high-density, low-cost biomanufacturing solutions, including the NevoLine vaccine platform (incl. inactivated polio vaccine), scale-X single-use bioreactors, Exothera viral vector CDMO, custom bioproduction hubs with preclinical to commercial GMP capabilities, turnkey advisory for local site design/operation/regulatory compliance, and Ntensify RNA production in mobile labs; engineered to cut investments >75% and cost of goods up to 90%.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Univercells company profile →
Arima Genomics
HQ: United States
Website
- Description: Provider of 3D genomics solutions including Arima-HiC to capture chromatin organization, Arima Capture-HiC for high-resolution targeted chromatin conformation, and Arima-HiChIP for protein-DNA interaction analysis; plus genome assembly of reference-quality, chromosome-spanning assemblies, and cancer genomics and human health offerings delivering insights into disease mechanisms, biomarkers, and therapeutic targets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arima Genomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Noroit
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Noroit
2.2 - Growth funds investing in similar companies to Noroit
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Noroit
4.2 - Public trading comparable groups for Noroit
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →